We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+0.24%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.6B
AUM Growth
+$1.47B
Cap. Flow
+$1.6B
Cap. Flow %
9.12%
Top 10 Hldgs %
17.57%
Holding
1,695
New
602
Increased
310
Reduced
364
Closed
414

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$207M
2
PFE icon
Pfizer
PFE
+$171M
3
JNJ icon
Johnson & Johnson
JNJ
+$140M
4
SSNC icon
SS&C Technologies
SSNC
+$132M
5
MSFT icon
Microsoft
MSFT
+$131M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$158M
2
META icon
Meta Platforms (Facebook)
META
+$120M
3
BKNG icon
Booking.com
BKNG
+$106M
4
MRK icon
Merck
MRK
+$93.9M
5
IDXX icon
Idexx Laboratories
IDXX
+$92.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.54%
2 Technology 21.21%
3 Consumer Discretionary 13.38%
4 Industrials 12.45%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NX icon
1026
Quanex
NX
$1.01B
$122K ﹤0.01%
+6,730
New +$121K
ABMD
1027
DELISTED
Abiomed Inc
ABMD
$122K ﹤0.01%
685
-4,105
-86% -$887K
KURA icon
1028
Kura Oncology
KURA
$850M
$121K ﹤0.01%
7,952
-61,717
-89% -$1.1M
WERN icon
1029
Werner Enterprises
WERN
$2.25B
$121K ﹤0.01%
+3,437
New +$112K
HQY icon
1030
HealthEquity
HQY
$8.75B
$120K ﹤0.01%
2,094
-29,068
-93% -$1.93M
GWR
1031
DELISTED
Genesee & Wyoming Inc.
GWR
$120K ﹤0.01%
+1,087
New +$120K
MFC icon
1032
Manulife Financial
MFC
$73.5B
$119K ﹤0.01%
6,500
-143,200
-96% -$2.53M
AXGN icon
1033
Axogen
AXGN
$2.5B
$118K ﹤0.01%
+9,465
New +$156K
DGII icon
1034
Digi International
DGII
$3.1B
$118K ﹤0.01%
+8,660
New +$114K
MBIN icon
1035
Merchants Bancorp
MBIN
$2.49B
$118K ﹤0.01%
+10,713
New +$119K
WTRE
1036
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
$118K ﹤0.01%
4,352
-5,688
-57% -$139K
PRQR icon
1037
ProQR Therapeutics
PRQR
$265M
$116K ﹤0.01%
+20,193
New +$161K
MAN icon
1038
ManpowerGroup
MAN
$2.63B
$115K ﹤0.01%
+1,371
New +$120K
MODV
1039
DELISTED
ModivCare
MODV
$114K ﹤0.01%
1,926
-3,942
-67% -$225K
SNDL icon
1040
Sundial Growers
SNDL
$320M
$114K ﹤0.01%
+2,389
New +$212K
AEM icon
1041
Agnico Eagle Mines
AEM
$90.5B
$113K ﹤0.01%
+2,100
New +$119K
ANDE icon
1042
Andersons Inc
ANDE
$2.22B
$110K ﹤0.01%
+4,882
New +$124K
TGS icon
1043
Transportadora de Gas del Sur
TGS
$4.33B
$109K ﹤0.01%
+13,376
New +$148K
WLDN icon
1044
Willdan Group
WLDN
$1.3B
$109K ﹤0.01%
+3,117
New +$111K
PBYI icon
1045
Puma Biotechnology
PBYI
$454M
$108K ﹤0.01%
+10,057
New +$109K
VPG icon
1046
Vishay Precision Group
VPG
$914M
$108K ﹤0.01%
+3,294
New +$118K
DIOD icon
1047
Diodes
DIOD
$4.84B
$106K ﹤0.01%
2,644
-39,747
-94% -$1.54M
RAMP icon
1048
LiveRamp
RAMP
$2.3B
$105K ﹤0.01%
2,443
-7,140
-75% -$332K
TGH
1049
DELISTED
Textainer Group Holdings limited
TGH
$105K ﹤0.01%
+10,622
New +$97.9K
ATCO
1050
DELISTED
Atlas Corp.
ATCO
$105K ﹤0.01%
9,902
-8,375
-46% -$87.3K
40 41
42
43 44

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2019 Portfolio in Review

As of Q3 2019, Marshall Wace North America held 1,695 positions worth $17.6B, up 9.1% from $16.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $1.6B of net new capital in Q3 2019, opening 602 new positions and adding to 310 existing holdings. Its largest new stake was Johnson & Johnson: 1,065,531 shares worth $138M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $120M trimmed.

  • Marshall Wace North America's largest Q3 2019 buy was Johnson & Johnson: 1,065,531 shares worth $138M.
  • Marshall Wace North America added most to Apple in Q3 2019, an estimated $207M increase.
  • Marshall Wace North America's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $120M.
  • Marshall Wace North America fully exited Abbott in Q3 2019, selling an estimated $158M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $17.6B portfolio in Q3 2019.
  • Marshall Wace North America opened 602 new positions and closed 414 in Q3 2019.
  • Marshall Wace North America's portfolio value rose 9.1% quarter-over-quarter to $17.6B.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.